Web27 okt. 2011 · LATUDA should be used with caution in patients with known cardiovascular disease (e.g., heart failure, history of myocardial infarction, ischemia, or conduction abnormalities), cerebrovascular ... Web27 mrt. 2024 · LATUDA and other medicines may affect each other causing serious side effects. LATUDA may affect the way other medicines work, and other medicines may affect how LATUDA works. Especially tell your healthcare provider if you take or plan to take medicines for: depression; high blood pressure; Parkinson's disease; trouble sleeping
Latuda: 7 things you should know - Drugs.com
WebLurasidone (Latuda) helps manage symptoms, but this medication does have common side effects ranging from mild to severe. Here’s what you need to know. Skip to main content WebFrontotemporal dementia is a group of disorders characterized by the loss of nerve cells in the frontal and temporal lobes of the brain, which causes these lobes to shrink. The cause of FTD is unknown. Symptoms typically first occur between the ages of 40 and 65 and can include changes in personality and behavior, progressive loss of speech and ... sas surveymeans
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European …
WebLurasidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and children 13 years of age and older. It is also used to treat depression in adults and children 10 years of age and older with bipolar disorder (manic ... WebLATUDA is indicated for the treatment of patients with schizophrenia. The efficacy of LATUDA in schizophrenia was established in four 6-week controlled studies of adult patients with schizophrenia [see Clinical Studies (14.1)]. The effectiveness of LATUDA for longer-term use, that is, for more than 6 weeks, has not been established WebLatuda (lurasidone) is a psychotropic agent belonging to the chemical class of benzoisothiazol derivatives. The mechanism of action of lurasidone is unknown, however has been suggested that the efficacy of lurasidone in schizophrenia is mediated through a combination of central dopamine Type 2 (D ) and serotonin Type 2 (5HT2A) receptor … sas supplier info